SCHEMBL246247

SCHEMBL246247

CNC(=O)c1c(-c2ccc(Oc3ccc(F)cc3)cc2)oc2cc[c]c(F)c12

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DDR2 Q16832 1/20 0.39
HIPK4 Q8NE63 1/20 0.39
SCN4A P35499 1/20 0.38
KCNH2 Q12809 6/20 0.38
CYP2C8 P10632 2/20 0.38
ANO1 Q5XXA6 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BCHE P06276 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
CYP3A4 P08684 1/20 0.36
BRAF P15056 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368951 0.93 KCNH2 (0.41) KCNH2CYP2C8HPGDCYP3A4
SCHEMBL253936 0.81 KCNH2 (0.47) DDR2HIPK4KCNH2CYP2C8
SCHEMBL244486 0.77 KCNH2 (0.41) DDR2HIPK4SCN4AKCNH2CYP2C8
SCHEMBL9947767 0.74 KCNH2 (0.41) DDR2HIPK4KCNH2CYP2C8ANO1
SCHEMBL2436747 0.73 AR (0.45) KCNH2CYP2C8HPGDCYP3A4
SCHEMBL16113969 0.73 KCNH2 (0.40) KCNH2CYP2C8ANO1CYP3A4
SCHEMBL2369389 0.73 CYP3A4 (0.44) KCNH2CYP2C8ANO1HPGDCYP3A4
SCHEMBL1918982 0.72 KCNH2 (0.52) KCNH2CYP2C8
SCHEMBL19197887 0.72 KCNH2 (0.50) KCNH2CYP2C8CYP3A4
SCHEMBL2842305 0.72 CYP3A4 (0.54) KCNH2CYP2C8ANO1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588464-A1 BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITS C Bristol-Myers Squibb Company (US) 2013-05-08 EP disclosed
WO-2012003164-A1 BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITS C BRISTOL-MYERS SQUIBB COMPANY (US) 2012-01-05 WO disclosed